BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29286565)

  • 1. Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection.
    Ronceray L; Abla O; Barzilai-Birenboim S; Bomken S; Chiang AK; Jazbec J; Kabickova E; Lazic J; Beishuizen A; Mellgren K; Tanaka F; Pillon M; Devalck C; Gouttenoire M; Makarova O; Burkhardt B; Attarbaschi A;
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of Upfront Therapy for Marginal Zone Lymphoma.
    Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-of-the-art therapeutics: marginal-zone lymphoma.
    Bertoni F; Zucca E
    J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
    Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
    Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma.
    Teckie S; Qi S; Chelius M; Lovie S; Hsu M; Noy A; Portlock C; Yahalom J
    Ann Oncol; 2017 May; 28(5):1064-1069. PubMed ID: 28327924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
    Tadmor T; Polliack A
    Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients.
    Boveri E; Arcaini L; Merli M; Passamonti F; Rizzi S; Vanelli L; Rumi E; Rattotti S; Lucioni M; Picone C; Castello A; Pascutto C; Magrini U; Lazzarino M; Paulli M
    Ann Oncol; 2009 Jan; 20(1):129-36. PubMed ID: 18718888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma.
    Traverse-Glehen A; Bertoni F; Thieblemont C; Zucca E; Coiffier B; Berger F; Salles G
    Oncology (Williston Park); 2012 Jan; 26(1):92-9, 103-4. PubMed ID: 22393802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
    Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
    Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL).
    Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Lee SI; Kang HJ; Choi CW; Park J; Song MK; Kim HJ; Kwon JH; Kwak JY; Bae SH; Park BB; Do YR; Lee HS; Jeong SH; Suh C; Kim HJ
    Int J Hematol; 2012 Nov; 96(5):631-7. PubMed ID: 23065471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma.
    Barzenje DA; Holte H; Fosså A; Ghanima W; Liestøl K; Delabie J; Kolstad A
    Leuk Lymphoma; 2017 Mar; 58(3):623-632. PubMed ID: 27389974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Bracci PM; Benavente Y; Turner JJ; Paltiel O; Slager SL; Vajdic CM; Norman AD; Cerhan JR; Chiu BC; Becker N; Cocco P; Dogan A; Nieters A; Holly EA; Kane EV; Smedby KE; Maynadié M; Spinelli JJ; Roman E; Glimelius B; Wang SS; Sampson JN; Morton LM; de Sanjosé S
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):52-65. PubMed ID: 25174026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal Zone Lymphoma: State-of-the-Art Treatment.
    Sindel A; Al-Juhaishi T; Yazbeck V
    Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Zucca E; Arcaini L; Buske C; Johnson PW; Ponzoni M; Raderer M; Ricardi U; Salar A; Stamatopoulos K; Thieblemont C; Wotherspoon A; Ladetto M;
    Ann Oncol; 2020 Jan; 31(1):17-29. PubMed ID: 31912792
    [No Abstract]   [Full Text] [Related]  

  • 15. The many faces of marginal zone lymphoma.
    Zinzani PL
    Hematology Am Soc Hematol Educ Program; 2012; 2012():426-32. PubMed ID: 23233614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal zone B-cell lymphoma in children and young adults.
    Taddesse-Heath L; Pittaluga S; Sorbara L; Bussey M; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2003 Apr; 27(4):522-31. PubMed ID: 12657939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
    Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
    Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction patterns of TRAP and DBA.44 in hairy cell leukemia, hairy cell variant, and nodal and extranodal marginal zone B-cell lymphomas.
    Dunphy CH
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):135-9. PubMed ID: 18227730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
    Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
    Olszewski AJ; Castillo JJ
    Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.